SR One Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
282
- Portfolio
-
30
- Exits
-
162
SR One General Information
Company Description
Founded in 1985, SR One is a corporate venture capital arm of GSK based in Redwood City, California. The firm seeks to invest in the life science, biotechnology, healthcare, medical devices, and information technology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.srone.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 929 Main Street
- Suite 200
- Redwood City, CA 94063
- United States
SR One Investments (282)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Dren Bio | 29-Oct-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Korsana Biosciences | 07-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Crystalys Therapeutics | 22-Jul-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Draig Therapeutics | 14-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Fore Biotherapeutics | 08-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Avenzo Therapeutics | 01-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Windward Bio Group | 12-May-2026 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Immutrin | 24-Mar-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Poplar Therapeutics | 09-Mar-2026 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| CORXEL Pharmaceuticals | 22-Jan-2026 | Later Stage VC | Drug Discovery | Generating Revenue |
SR One Exits (162)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Windward Bio Group | 03-Nov-2026 | IPO | |
| Simcha Therapeutics | 26-Oct-2026 | ||
| ADARx Pharmaceuticals | 25-Sep-2026 | ||
| Kartos Therapeutics | 20-Aug-2026 | ||
| Odyssey Therapeutics | 07-May-2026 | ||
| Avalyn Pharma | 30-Apr-2026 | ||
| VeraDermics | 29-Apr-2026 | ||
| Oruka Therapeutics | 28-Apr-2026 | ||
| Zenas BioPharma | 26-Mar-2026 | Public Investment 2nd Offering | |
| VeraDermics | 03-Feb-2026 | IPO |
SR One Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
SR One Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
SR One Co-Investors (218)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 12 |
|
|
||
| HBM Healthcare Investments |
|
|
|||
| Novo Holdings |
|
|
|||
| RA Capital Management |
|
|
|||
| Cormorant Asset Management |
|
|
SR One FAQs
-
What is SR One?
Founded in 1985, SR One is a corporate venture capital arm of GSK based in Redwood City, California.
-
When was SR One founded?
SR One was founded in 1985.
-
Where is SR One headquartered?
SR One is headquartered in Redwood City, CA.
-
What is SR One's total asset value?
SR One has around in total assets under management.
-
How many investments has SR One made?
SR One has made 282 investments.
-
What has SR One invested in?
SR One has made numerous investments in companies like Dren Bio, Korsana Biosciences, and Crystalys Therapeutics within the Drug Discovery industry.
-
What has SR One invested in recently?
SR One's latest investment was on 29-Oct-2026 in Dren Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
